2012-02-14 07:09:14 -

Analytik Jena AG /
Analytik Jena Announces Financial Figures for the First Quarter 2011/2012
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

  * Revenue and EBIT in line with expectations
  * Net profit and EPS increased by 3.7 % or by 13.6 %
  * Operating cashflow up 33.4 % year-on-year

Jena (Germany), February 14, 2012 - Analytik Jena AG (Prime Standard: AJA, ISIN:
DE0005213508) has made a good start into the financial year 2011/2012. After
three months consolidated revenue of EUR 23.2 m (previous year: EUR 23.7 m) was
achieved and remained largely stable year-on-year. Overall, the Group generated
a net profit for the period of EUR 1.5 m. Earnings per share were   EUR 0.25
(previous year: EUR 0.22).

"We are satisfied with the results achieved in the first quarter. Overall, we
are in line with our expectations. Both regarding revenue and earnings, without
large-scale orders we were successfull to build on a strong quarter last year",
said Klaus Berka, CEO of Analytik Jena AG. "We expect to reach and to exceed
previous-year level already in the second quarter."

Revenue Development and Segments

In what is by far the most important export market for Analytik Jena, sales in
Asia again rose in double digits, by 15.4 %. Over here, the Group generated
overall revenue of EUR 7.8 m (previous year: EUR 6.8 m). In the America sales
region revenue totaled EUR 2.0 m (previous year: EUR 1.6 m). On its home market,
Analytik Jena posted sales of EUR 6.9 m (previous year: EUR 8.1 m) and in Europe
EUR 5.8 m (previous year: EUR 6.6 m). After three months, due to the regional
shift of sales to Asia, the export ratio was 70.1 % (previous year: 66.0 %).

The biggest segment, Analytical Instrumentation was down only 2.7 % year-on-year
with sales of EUR 14.1 m. Analytik Jena anticipates the segment will compensate
for the decline in sales in the third quarter and on a whole-year basis again
exceed the previous-year sales level.

Despite good end-of-year business in 2011, in the first quarter of 2011/2012
Life Science sales also declined slightly year-on-year, by 0.9 %. This is due
particularly to declining sales at CyBio AG (consolidated in this segment) not
reaching the strong level of the previous year. After three months, revenue in
Life Science segment totaled EUR 7.9 m (previous year: EUR 8.0 m).

In the reporting period, in the Optics consumer segment Analytik Jena generated
EUR 1.1 m (previous year: EUR 1.2 m), 7.7 % less than in the previous year. In
the second quarter, the segment will again be able to grow through the extension
of the service portfolio as OEM vendor. Analytik Jena was successful in
acquiring an additional order volume of EUR 1.1 m for special optical products
and components.

Earnings

After three months in the current financial year the Group posted net profit for
the period of EUR 1.5 m (previous year: EUR 1.4 m). That corresponds to an
increase of 3.7 % compared to last year's period. Earnings per share were at EUR
0.25 (previous year: EUR 0.22). The Company benefited especially from the
development of the USD at the end of the quarter. Correspondingly, the financial
result and EBT developed positively. The Group posted total EBT of EUR 2.1 m
(previous year: EUR 2.0 m), an upturn of 3.7 %. EBITDA fell by 9.1 % to EUR 2.9
m (previous year: EUR 3.2 m). In the past quarter, the Group posted an operating
profit (EBIT) of EUR 1.9 m (previous year: EUR 2.2 m), 15.9 % down year-on-year.
The Company achieved an EBIT margin of 8.2 % compared with 9.5 % in the same
quarter of the previous year.

Changes in Statement of Financial Position

The Group's total assets remained nearly constant at EUR 84.1 m as of December
31, 2011. This compared with EUR 83.6 m (September 30, 2011). In the reporting
period, Analytik Jena reported equity of EUR 39.8 m (September 30, 2011: EUR
38.6 m), representing an increase of 3.1 % and a rise in the equity ratio from
46.1 % as of September 30, 2011 to 47.3 % as of December 31, 2011. Cash and cash
equivalents totaled EUR 6.0 m as of the end of the reporting period (September
30, 2011: EUR 5.5 m). This corresponds to a year-on-year increase of 9.1 % and
is primarily the result of the 33.4 % rise in operating cashflow (EUR 1.7 m
after three months, previous year: EUR 1.3 m).

Human Resources

As of the balance sheet date December 31, 2011, the Group employed 807 staff,
including 39 trainees (previous year: 799 employees, including 46 trainees).

Outlook

For the rest of the financial year, Analytik Jena anticipates that the
conditions affecting its business activities will remain largely the same. The
Company expects to achieve profitable cross-segment growth with its entire
portfolio in the current financial year 2011/2012.

For the second quarter, the Company anticipates sales will remain stable and
results to be good.

As usual, Analytik Jena will announce its outlook for the entire financial year
at the Annual General Meeting on April 24, 2012.



Further Information

The full financial report can be accessed at  berichte.analytik-jena.de/3-
MonthReport_1112.pdf.

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena/Germany
Tel. +49 3641 779281
Email: ir@analytik-jena.com







This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Analytik Jena AG via Thomson Reuters ONE

[HUG#1585263]